Biocon Limited (BSE: 532523; NSE: BIOCON) today announced the appointment of Shreehas Tambe as its Chief Executive Officer & ...

Biocon's Siddharth Mittal steps down as MD & CEO; Shreehas Tambe, a 30-year company veteran with 61 patents, takes over from ...

Biocon has announced a series of top-level leadership changes, including the appointment of Shreehas Pradeep Tambe as its new chief executive officer and managing director, effective 1 April 2026.

Leadership transition aligns with Biocon’s integration of biologics and generics into a unified global biopharma platform.

Biocon Ltd on Friday said it has appointed Shreehas Tambe as CEO & Managing Director, effective April 1, 2026.

Biocon Limited has appointed Shreehas Tambe as its Chief Executive Officer and Managing Director, effective April 1, 2026, as ...

Tambe, a nearly three‑decade Biocon veteran, will be the first CEO to lead the unified platform after Biocon Biologics was ...

Biocon announced a leadership change. Siddharth Mittal will step down as Managing Director and Chief Executive Officer on ...

The leadership transition is part of the full integration of Biocon Biologics Ltd. as a wholly-owned subsidiary of Biocon Ltd ...

Shares of Biocon fell on Friday, March 27, after Siddharth Mittal resigned as CEO and MD, who will transition to a new role ...

Biocon Biologics has been positioning itself to become a global player in biosimilar drugs. Viatris, a longtime partner to Biocon, is charting a course for its future that does not include biosimilars ...